United States· US:63187-937_71114f1d-474e-46e1-9bcd-cdf746046b9a
Flurbiprofen Sodium
A flurbiprofen product containing flurbiprofen sodium, registered in United States by Proficient Rx LP. The same ATC class is registered in 2 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Flurbiprofen is registered in 2 of 19 countries.
Countries holding a registration under ATC S01BC04 (flurbiprofen), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 1 of them publish a price we can compare per daily dose
Flurbiprofen · ATC S01BC04
2 / 19 countries
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- FLURBIPROFEN SODIUM
- Manufacturer
- Proficient Rx LP
- Country
- United States (US)
- ATC code
- S01BC04
- ATC class
- Flurbiprofen
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1163187-937-25
- ndc1163187937251 BOTTLE, DROPPER in 1 CARTON (63187-937-25) / 2.5 mL in 1 BOTTLE, DROPPER
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
90 interactions on record for flurbiprofen.
Graded by severity as the source publishes them — 89 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Flurbiprofen · interactions on record
90 records
- 89 moderate
- 1 minor
Most severe, free to view
- DicoumarolB01AA01moderate
- WarfarinB01AA03moderate
- HeparinB01AB01moderate
- Antithrombin IIIB01AB02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under S01BC04
Flurbiprofen, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/322ea105-5033-478a-bf51-af5fe33cb6de GET /v1/drugs/322ea105-5033-478a-bf51-af5fe33cb6de?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "OPHTHALMIC",
"source": "ndc",
"strength": ".3",
"substance": "FLURBIPROFEN SODIUM",
"productndc": "63187-937",
"dosage_form": "SOLUTION/ DROPS",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "ANDA074447",
"marketing_category": "ANDA"
}See everything about flurbiprofen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.